Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Australian asthma deaths fall, mostly in women: ABS
The National Asthma Council has highlighted the vital role community pharmacists can play in identifying at-risk patients, following a drop in overall asthma deaths...
Moving pharmacy forward
Australia’s healthcare system is strained but there is immense scope for the role of pharmacists to address the sector’s future burdens.
At a time of...
Complementary medicines during cold and flu season
As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...
Ready-to-use tool for oncology
Pharmacists have a new oncology-focused tool for the evaluation and assessment of adverse drug events in oncology.
French researchers have developed a trigger tool to...
Practice advice Q&A: Fax machines
How can our medical system still rely so heavily on the fax machine for crucial communications? What are the modern alternatives?
Prior to the inception...
Patients with COPD terrified of contracting COVID-19
After almost 2 years of the COVID-19 pandemic, pharmacists must emphasise the importance of maintaining lung health on World COPD Day (17 November).
